NUDT1 and cancer: The inability to kill some cancer cells by MTH1 knockdown [33], together with the resistance of some cell lines to treatment with highly specific MTH1 inhibitors [33, 34] and failure to rescue sensitive cells by overexpression of human MTH1 or the bacterial homolog that shares the enzymatic activity [35] have casted doubts on the mechanism of action of the inhibitors.